// App-Quantinova.ai

AB0557 : CO-EXISTENCE OF SYSTEMIC SCLEROSIS HALLMARK AUTOANTIBODIES ASSOCIATES WITH DISTINCT CLINICAL PHENOTYPE

Researchers

Presenter

  • C. Campochiaro

Principal Investigators

  • K. Clark

  • L. Host

  • A. Sari

  • S. Nihtyanova

  • C. Denton

  • V. Ong

Medical Centers

  • Centre for Rheumatology and Connective Tissue Disease, UCL Medical School Royal Free Campus, London, United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GSK plc

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved